We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$18.8B
AUM Growth
+$1.08B
Cap. Flow
+$375M
Cap. Flow %
1.99%
Top 10 Hldgs %
32.3%
Holding
1,384
New
65
Increased
662
Reduced
357
Closed
63

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$243M
2
PLD icon
Prologis
PLD
+$106M
3
DLR icon
Digital Realty Trust
DLR
+$97.4M
4
KIM icon
Kimco Realty
KIM
+$96.3M
5
SNOW icon
Snowflake
SNOW
+$88.7M

Top Sells

Rank Stock Value
1
O icon
Realty Income
O
+$225M
2
INVH icon
Invitation Homes
INVH
+$153M
3
EQIX icon
Equinix
EQIX
+$91.3M
4
SPG icon
Simon Property Group
SPG
+$91.1M
5
AMT icon
American Tower
AMT
+$91M

Sector Composition

Rank Sector Weight
1 Real Estate 42.05%
2 Technology 19.13%
3 Communication Services 6.55%
4 Consumer Discretionary 6.17%
5 Financials 5.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DBC icon
1176
Invesco DB Commodity Index Tracking Fund
DBC
$1.67B
$5K ﹤0.01%
200
IMCR icon
1177
Immunocore
IMCR
$1.72B
$5K ﹤0.01%
138
KURA icon
1178
Kura Oncology
KURA
$901M
$5K ﹤0.01%
227
LGND icon
1179
Ligand Pharmaceuticals
LGND
$5.96B
$5K ﹤0.01%
63
MIRM icon
1180
Mirum Pharmaceuticals
MIRM
$6.96B
$5K ﹤0.01%
148
PCRX icon
1181
Pacira BioSciences
PCRX
$1.04B
$5K ﹤0.01%
169
VIR icon
1182
Vir Biotechnology
VIR
$1.48B
$5K ﹤0.01%
535
VSH icon
1183
PUT
Vishay Intertechnology
VSH
$5.7B
$5K ﹤0.01%
500
-809
-62% -$18.3K
MORF
1184
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$5K ﹤0.01%
155
ANIP icon
1185
ANI Pharmaceuticals
ANIP
$1.78B
$4K ﹤0.01%
70
ARQT icon
1186
Arcutis Biotherapeutics
ARQT
$3.48B
$4K ﹤0.01%
439
+194
+79% +$1.75K
BCRX icon
1187
BioCryst Pharmaceuticals
BCRX
$2.43B
$4K ﹤0.01%
692
CGEM icon
1188
Cullinan Oncology
CGEM
$1.07B
$4K ﹤0.01%
218
+91
+72% +$1.94K
COLL icon
1189
Collegium Pharmaceutical
COLL
$1.15B
$4K ﹤0.01%
127
DAWN
1190
DELISTED
Day One Biopharmaceuticals
DAWN
$4K ﹤0.01%
296
DVAX
1191
DELISTED
Dynavax Technologies
DVAX
$4K ﹤0.01%
379
-150
-28% -$1.75K
ELVN icon
1192
Enliven Therapeutics
ELVN
$3.77B
$4K ﹤0.01%
152
FDMT icon
1193
4D Molecular Therapeutics
FDMT
$543M
$4K ﹤0.01%
184
-5,390
-97% -$135K
MRVI icon
1194
Maravai LifeSciences
MRVI
$987M
$4K ﹤0.01%
490
PRTA icon
1195
Prothena Corp
PRTA
$455M
$4K ﹤0.01%
195
SANA icon
1196
Sana Biotechnology
SANA
$913M
$4K ﹤0.01%
767
SUPN icon
1197
Supernus Pharmaceuticals
SUPN
$2.73B
$4K ﹤0.01%
157
-60
-28% -$1.74K
VRNA
1198
DELISTED
Verona Pharma
VRNA
$4K ﹤0.01%
244
XLF icon
1199
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$4K ﹤0.01%
+107
New +$4.4K
XNCR icon
1200
Xencor
XNCR
$1.47B
$4K ﹤0.01%
222

Similar funds

Daiwa Securities Group's Q2 2024 Portfolio in Review

As of Q2 2024, Daiwa Securities Group held 1,384 positions worth $18.8B, up 6.1% from $17.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Daiwa Securities Group's Q2 2024 filing shows 65 new, 662 increased, 357 reduced and 63 closed positions. Its largest new stake was NextEra Energy 7.299% Corporate Units: 500,000 shares worth $24.6M. The largest sale was Realty Income, an estimated $225M.

By sector, the portfolio is most concentrated in Real Estate at 42% of assets, down from 46% a quarter earlier, followed by Technology and Communication Services.

  • Daiwa Securities Group's largest Q2 2024 buy was NextEra Energy 7.299% Corporate Units: 500,000 shares worth $24.6M.
  • Daiwa Securities Group added most to Crown Castle in Q2 2024, an estimated $243M increase.
  • Daiwa Securities Group's biggest Q2 2024 reduction was Realty Income, cutting an estimated $225M.
  • Daiwa Securities Group fully exited Apartment Income REIT Corp. in Q2 2024, selling an estimated $88.4M.
  • Daiwa Securities Group's ten largest holdings make up 32% of its $18.8B portfolio in Q2 2024.
  • Daiwa Securities Group opened 65 new positions and closed 63 in Q2 2024.
  • Daiwa Securities Group's portfolio value rose 6.1% quarter-over-quarter to $18.8B.

Based on Daiwa Securities Group's 13F filing for Q2 2024, filed 7 Aug 2024.